25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Bioxyne Ltd
Buy, Hold or Sell?

Let's analyze Bioxyne together

I guess you are interested in Bioxyne Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bioxyne Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bioxyne Ltd

I send you an email if I find something interesting about Bioxyne Ltd.

1. Quick Overview

1.1. Quick analysis of Bioxyne (30 sec.)










1.2. What can you expect buying and holding a share of Bioxyne? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$-0.02
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.02
Return On Investment
-51.9%

For what price can you sell your share?

Current Price per Share
A$0.04
Expected price per share
A$0.028 - A$
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bioxyne (5 min.)




Live pricePrice per Share (EOD)
A$0.04
Intrinsic Value Per Share
A$-0.03 - A$-0.01
Total Value Per Share
A$-0.03 - A$-0.01

2.2. Growth of Bioxyne (5 min.)




Is Bioxyne growing?

Current yearPrevious yearGrowGrow %
How rich?$2m$9.5m-$7.4m-354.8%

How much money is Bioxyne making?

Current yearPrevious yearGrowGrow %
Making money-$8.4m-$1.2m-$7.2m-85.4%
Net Profit Margin-142.9%-37.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Bioxyne (5 min.)




2.4. Comparing to competitors in the Packaged Foods industry (5 min.)




  Industry Rankings (Packaged Foods)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bioxyne?

Welcome investor! Bioxyne's management wants to use your money to grow the business. In return you get a share of Bioxyne.

First you should know what it really means to hold a share of Bioxyne. And how you can make/lose money.

Speculation

The Price per Share of Bioxyne is A$0.044. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bioxyne.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bioxyne, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bioxyne.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-9.4%0.00-9.4%0.00-1.4%0.00-2.3%0.00-1.4%
Usd Book Value Change Per Share0.00-8.2%0.00-8.2%0.0010.8%0.000.0%0.000.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-8.2%0.00-8.2%0.0010.8%0.000.0%0.000.2%
Usd Price Per Share0.00-0.00-0.01-0.01-0.01-
Price to Earnings Ratio-0.77--0.77--20.86--55.18--8.56-
Price-to-Total Gains Ratio-0.88--0.88-2.67--26.46-68.89-
Price to Book Ratio3.11-3.11-2.73--4.64-7.18-
Price-to-Total Gains Ratio-0.88--0.88-2.67--26.46-68.89-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0279576
Number of shares35768
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (35768 shares)-129.830.35
Gains per Year (35768 shares)-519.331.40
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-519-52901-9
20-1039-104803-8
30-1558-156704-7
40-2077-208606-6
50-2597-260507-5
60-3116-312408-4
70-3635-3643010-3
80-4155-4162011-2
90-4674-4681013-1
100-5193-52000140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%5.019.01.020.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%5.05.00.050.0%13.012.00.052.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.025.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%5.05.00.050.0%13.012.00.052.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bioxyne Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.006-0.0060%0.008-176%0.000-37273%0.000-5355%
Book Value Per Share--0.0020.0020%0.007-78%0.002-27%0.002-11%
Current Ratio--1.9211.9210%2.248-15%2.452-22%3.926-51%
Debt To Asset Ratio--0.5070.5070%0.152+234%0.597-15%0.385+32%
Debt To Equity Ratio--0.9420.9420%0.178+431%0.360+162%0.286+230%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--7876060.7607876060.7600%42143580.040-81%30722229.880-74%40997808.259-81%
Eps---0.007-0.0070%-0.001-85%-0.002-75%-0.001-85%
Ev To Ebitda Ratio---4.749-4.7490%-22.410+372%-58.171+1125%-88.542+1765%
Ev To Sales Ratio--0.8450.8450%8.167-90%19.510-96%22.246-96%
Free Cash Flow Per Share---0.002-0.0020%0.000-78%-0.001-73%0.000-77%
Free Cash Flow To Equity Per Share---0.001-0.0010%0.000-5872%0.000-79%0.000-92%
Gross Profit Margin--1.0311.0310%1.342-23%1.304-21%1.111-7%
Intrinsic Value_10Y_max---0.014--------
Intrinsic Value_10Y_min---0.031--------
Intrinsic Value_1Y_max---0.001--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max---0.003--------
Intrinsic Value_3Y_min---0.006--------
Intrinsic Value_5Y_max---0.005--------
Intrinsic Value_5Y_min---0.012--------
Market Cap90166117.888+89%10246149.76010246149.7600%40984599.040-75%30738449.280-67%40164907.059-74%
Net Profit Margin---1.429-1.4290%-0.376-74%-0.674-53%-0.469-67%
Operating Margin---0.203-0.2030%-0.386+90%-0.429+111%-0.366+80%
Operating Ratio--1.1811.1810%1.398-15%1.417-17%1.345-12%
Pb Ratio27.327+89%3.1053.1050%2.731+14%-4.636+249%7.184-57%
Pe Ratio-6.767-780%-0.769-0.7690%-20.863+2613%-55.181+7076%-8.558+1013%
Price Per Share0.044+89%0.0050.0050%0.020-75%0.015-67%0.020-74%
Price To Free Cash Flow Ratio-22.249-780%-2.528-2.5280%-45.644+1705%851.999-100%407.804-101%
Price To Total Gains Ratio-7.702-780%-0.875-0.8750%2.666-133%-26.459+2923%68.894-101%
Quick Ratio--0.9230.9230%1.806-49%1.710-46%3.279-72%
Return On Assets---1.990-1.9900%-0.110-94%-0.714-64%-0.407-80%
Return On Equity---3.695-3.6950%-0.128-97%-0.864-77%-0.492-87%
Total Gains Per Share---0.006-0.0060%0.008-176%0.000-37273%0.000-5355%
Usd Book Value--2096537.8822096537.8820%9534898.179-78%2856652.797-27%2345160.562-11%
Usd Book Value Change Per Share---0.004-0.0040%0.005-176%0.000-37273%0.000-5355%
Usd Book Value Per Share--0.0010.0010%0.005-78%0.001-27%0.001-11%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--5004449.0075004449.0070%26778030.757-81%19520904.866-74%26050007.368-81%
Usd Eps---0.004-0.0040%-0.001-85%-0.001-75%-0.001-85%
Usd Free Cash Flow---2575029.665-2575029.6650%-570539.639-78%-696824.626-73%-585205.179-77%
Usd Free Cash Flow Per Share---0.001-0.0010%0.000-78%0.000-73%0.000-77%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%0.000-5872%0.000-79%0.000-92%
Usd Market Cap57291551.306+89%6510403.5586510403.5580%26041614.230-75%19531210.673-67%25520781.945-74%
Usd Price Per Share0.028+89%0.0030.0030%0.013-75%0.010-67%0.012-74%
Usd Profit---8466736.770-8466736.7700%-1232656.938-85%-2141026.303-75%-1255960.297-85%
Usd Revenue--5925117.7085925117.7080%3279005.845+81%2455037.552+141%1867836.963+217%
Usd Total Gains Per Share---0.004-0.0040%0.005-176%0.000-37273%0.000-5355%
 EOD+5 -3MRQTTM+0 -0YOY+5 -335Y+8 -3010Y+7 -31

3.3 Fundamental Score

Let's check the fundamental score of Bioxyne Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.767
Price to Book Ratio (EOD)Between0-127.327
Net Profit Margin (MRQ)Greater than0-1.429
Operating Margin (MRQ)Greater than0-0.203
Quick Ratio (MRQ)Greater than10.923
Current Ratio (MRQ)Greater than11.921
Debt to Asset Ratio (MRQ)Less than10.507
Debt to Equity Ratio (MRQ)Less than10.942
Return on Equity (MRQ)Greater than0.15-3.695
Return on Assets (MRQ)Greater than0.05-1.990
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Bioxyne Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.047
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Bioxyne Ltd

Bioxyne Limited, a life sciences and consumer health products company, engages in the manufacture and distribution of consumer health products, patented probiotics, health supplements, therapeutic goods, and alternative medicines. The company manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabinoids, cannabis extracts, cannabis pastilles, THC flowers, vapes, oral liquids, nootropic and skin care products, and mushroom complexes. It also develops various functional food products, such as lactobacillus fermentum VRI-003 for over-the counter gut health immune supplement products. In addition, the company provides product research and development services, and telemedicine services. Further, it operates BLS Clinics, a telehealth platform; and CanXChange Australia, a machine-learning driven B2B technology platform for sponsors, manufacturers, cultivators, and pharmacies to interact, manage chain of custody, and buy and sell bulk starting materials, APIs, and finished products in a regulated environment. The company offers its products under the Dr Watson, Mirai Solution, and Apothecary CBD brands. It provides its products online, as well as through wholesale and direct sales in Australia, the United States, the United Kingdom, Japan, Czechia, Switzerland, France, and Germany. The company was incorporated in 1998 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2025-02-15 08:39:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Bioxyne earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • A Net Profit Margin of -142.9% means that $-1.43 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bioxyne Ltd:

  • The MRQ is -142.9%. The company is making a huge loss. -2
  • The TTM is -142.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-142.9%TTM-142.9%0.0%
TTM-142.9%YOY-37.6%-105.3%
TTM-142.9%5Y-67.4%-75.5%
5Y-67.4%10Y-46.9%-20.4%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-142.9%3.5%-146.4%
TTM-142.9%3.3%-146.2%
YOY-37.6%2.7%-40.3%
5Y-67.4%3.3%-70.7%
10Y-46.9%3.4%-50.3%
4.3.1.2. Return on Assets

Shows how efficient Bioxyne is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • -199.0% Return on Assets means that Bioxyne generated $-1.99 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bioxyne Ltd:

  • The MRQ is -199.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -199.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-199.0%TTM-199.0%0.0%
TTM-199.0%YOY-11.0%-188.0%
TTM-199.0%5Y-71.4%-127.5%
5Y-71.4%10Y-40.7%-30.7%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-199.0%1.2%-200.2%
TTM-199.0%1.2%-200.2%
YOY-11.0%1.0%-12.0%
5Y-71.4%1.2%-72.6%
10Y-40.7%1.2%-41.9%
4.3.1.3. Return on Equity

Shows how efficient Bioxyne is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • -369.5% Return on Equity means Bioxyne generated $-3.70 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bioxyne Ltd:

  • The MRQ is -369.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -369.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-369.5%TTM-369.5%0.0%
TTM-369.5%YOY-12.8%-356.7%
TTM-369.5%5Y-86.4%-283.1%
5Y-86.4%10Y-49.2%-37.2%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-369.5%2.5%-372.0%
TTM-369.5%2.5%-372.0%
YOY-12.8%2.1%-14.9%
5Y-86.4%2.4%-88.8%
10Y-49.2%2.6%-51.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bioxyne Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Bioxyne is operating .

  • Measures how much profit Bioxyne makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • An Operating Margin of -20.3% means the company generated $-0.20  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bioxyne Ltd:

  • The MRQ is -20.3%. The company is operating very inefficient. -2
  • The TTM is -20.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-20.3%TTM-20.3%0.0%
TTM-20.3%YOY-38.6%+18.3%
TTM-20.3%5Y-42.9%+22.6%
5Y-42.9%10Y-36.6%-6.3%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.3%5.1%-25.4%
TTM-20.3%5.2%-25.5%
YOY-38.6%3.7%-42.3%
5Y-42.9%4.2%-47.1%
10Y-36.6%4.9%-41.5%
4.3.2.2. Operating Ratio

Measures how efficient Bioxyne is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • An Operation Ratio of 1.18 means that the operating costs are $1.18 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bioxyne Ltd:

  • The MRQ is 1.181. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.181. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.181TTM1.1810.000
TTM1.181YOY1.398-0.216
TTM1.1815Y1.417-0.236
5Y1.41710Y1.345+0.072
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1811.307-0.126
TTM1.1811.232-0.051
YOY1.3981.122+0.276
5Y1.4171.109+0.308
10Y1.3451.053+0.292
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bioxyne Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bioxyne is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Packaged Foods industry mean).
  • A Current Ratio of 1.92 means the company has $1.92 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bioxyne Ltd:

  • The MRQ is 1.921. The company is able to pay all its short-term debts. +1
  • The TTM is 1.921. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.921TTM1.9210.000
TTM1.921YOY2.248-0.327
TTM1.9215Y2.452-0.531
5Y2.45210Y3.926-1.474
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9211.578+0.343
TTM1.9211.584+0.337
YOY2.2481.604+0.644
5Y2.4521.652+0.800
10Y3.9261.669+2.257
4.4.3.2. Quick Ratio

Measures if Bioxyne is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • A Quick Ratio of 0.92 means the company can pay off $0.92 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bioxyne Ltd:

  • The MRQ is 0.923. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.923. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.923TTM0.9230.000
TTM0.923YOY1.806-0.883
TTM0.9235Y1.710-0.787
5Y1.71010Y3.279-1.569
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9230.590+0.333
TTM0.9230.616+0.307
YOY1.8060.652+1.154
5Y1.7100.716+0.994
10Y3.2790.792+2.487
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bioxyne Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Bioxyne assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bioxyne to Packaged Foods industry mean.
  • A Debt to Asset Ratio of 0.51 means that Bioxyne assets are financed with 50.7% credit (debt) and the remaining percentage (100% - 50.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bioxyne Ltd:

  • The MRQ is 0.507. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.507. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.507TTM0.5070.000
TTM0.507YOY0.152+0.355
TTM0.5075Y0.597-0.090
5Y0.59710Y0.385+0.212
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5070.471+0.036
TTM0.5070.472+0.035
YOY0.1520.489-0.337
5Y0.5970.482+0.115
10Y0.3850.486-0.101
4.5.4.2. Debt to Equity Ratio

Measures if Bioxyne is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bioxyne to the Packaged Foods industry mean.
  • A Debt to Equity ratio of 94.2% means that company has $0.94 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bioxyne Ltd:

  • The MRQ is 0.942. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.942. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.942TTM0.9420.000
TTM0.942YOY0.178+0.765
TTM0.9425Y0.360+0.582
5Y0.36010Y0.286+0.074
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9420.894+0.048
TTM0.9420.912+0.030
YOY0.1780.974-0.796
5Y0.3600.992-0.632
10Y0.2861.052-0.766
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bioxyne generates.

  • Above 15 is considered overpriced but always compare Bioxyne to the Packaged Foods industry mean.
  • A PE ratio of -0.77 means the investor is paying $-0.77 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bioxyne Ltd:

  • The EOD is -6.767. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.769. Based on the earnings, the company is expensive. -2
  • The TTM is -0.769. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.767MRQ-0.769-5.998
MRQ-0.769TTM-0.7690.000
TTM-0.769YOY-20.863+20.094
TTM-0.7695Y-55.181+54.412
5Y-55.18110Y-8.558-46.623
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-6.76712.572-19.339
MRQ-0.76912.542-13.311
TTM-0.76912.485-13.254
YOY-20.86313.353-34.216
5Y-55.18116.289-71.470
10Y-8.55819.293-27.851
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bioxyne Ltd:

  • The EOD is -22.249. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.528. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.528. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-22.249MRQ-2.528-19.721
MRQ-2.528TTM-2.5280.000
TTM-2.528YOY-45.644+43.116
TTM-2.5285Y851.999-854.528
5Y851.99910Y407.804+444.195
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-22.2495.853-28.102
MRQ-2.5286.360-8.888
TTM-2.5284.642-7.170
YOY-45.6441.459-47.103
5Y851.9991.636+850.363
10Y407.8041.839+405.965
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Bioxyne is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • A PB ratio of 3.11 means the investor is paying $3.11 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bioxyne Ltd:

  • The EOD is 27.327. Based on the equity, the company is expensive. -2
  • The MRQ is 3.105. Based on the equity, the company is fair priced.
  • The TTM is 3.105. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD27.327MRQ3.105+24.221
MRQ3.105TTM3.1050.000
TTM3.105YOY2.731+0.374
TTM3.1055Y-4.636+7.741
5Y-4.63610Y7.184-11.820
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD27.3271.422+25.905
MRQ3.1051.449+1.656
TTM3.1051.559+1.546
YOY2.7311.593+1.138
5Y-4.6361.927-6.563
10Y7.1842.508+4.676
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bioxyne Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Current Deferred Revenue -486438-47-350-397-161-55959537



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets6,698
Total Liabilities3,398
Total Stockholder Equity3,606
 As reported
Total Liabilities 3,398
Total Stockholder Equity+ 3,606
Total Assets = 6,698

Assets

Total Assets6,698
Total Current Assets5,585
Long-term Assets1,113
Total Current Assets
Cash And Cash Equivalents 1,028
Net Receivables 1,655
Inventory 2,142
Other Current Assets 760
Total Current Assets  (as reported)5,585
Total Current Assets  (calculated)5,585
+/-0
Long-term Assets
Property Plant Equipment 824
Goodwill 288
Other Assets 0
Long-term Assets  (as reported)1,113
Long-term Assets  (calculated)1,113
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities2,907
Long-term Liabilities491
Total Stockholder Equity3,606
Total Current Liabilities
Short-term Debt 183
Accounts payable 1,193
Other Current Liabilities 1,495
Total Current Liabilities  (as reported)2,907
Total Current Liabilities  (calculated)2,871
+/- 37
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt491
Long-term Liabilities  (as reported)491
Long-term Liabilities  (calculated)491
+/-0
Total Stockholder Equity
Common Stock18,998
Retained Earnings -15,604
Accumulated Other Comprehensive Income 212
Total Stockholder Equity (as reported)3,606
Total Stockholder Equity (calculated)3,606
+/-0
Other
Capital Stock18,998
Cash and Short Term Investments 1,028
Common Stock Shares Outstanding 1,930,248
Current Deferred Revenue37
Liabilities and Stockholders Equity 6,698
Net Debt -354
Net Invested Capital 3,606
Net Working Capital 2,678
Property Plant and Equipment Gross 1,008
Short Long Term Debt Total 674



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-30
> Total Assets 
12,543
9,564
4,898
1,980
2,379
1,301
1,073
610
482
486
299
221
6,910
702
1,499
1,513
2,010
4,740
5,050
3,971
3,335
2,679
446
17,693
6,698
6,69817,6934462,6793,3353,9715,0504,7402,0101,5131,4997026,9102212994864826101,0731,3012,3791,9804,8989,56412,543
   > Total Current Assets 
12,502
9,370
4,688
1,814
2,220
1,172
995
552
466
479
294
218
2,472
701
1,174
1,188
1,685
4,514
4,735
3,519
3,070
2,510
403
6,040
5,585
5,5856,0404032,5103,0703,5194,7354,5141,6851,1881,1747012,4722182944794665529951,1722,2201,8144,6889,37012,502
       Cash And Cash Equivalents 
12,498
260
963
1,350
1,074
403
209
299
197
86
238
112
780
211
992
958
1,354
3,876
3,310
1,768
1,748
1,602
66
3,846
1,028
1,0283,846661,6021,7481,7683,3103,8761,354958992211780112238861972992094031,0741,35096326012,498
       Short-term Investments 
0
0
0
120
805
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000805120000
       Net Receivables 
4
9,105
3,633
213
618
381
679
91
244
393
56
106
1,692
107
121
172
294
486
707
759
304
335
253
1,008
1,655
1,6551,0082533353047597074862941721211071,69210656393244916793816182133,6339,1054
       Inventory 
0
-1
0
72
440
364
92
158
25
0
0
0
0
0
0
0
0
101
629
714
768
370
76
995
2,142
2,14299576370768714629101000000002515892364440720-10
   > Long-term Assets 
41
194
209
166
159
129
79
58
16
7
4
3
4,438
1
325
325
325
53
211
390
265
168
43
11,653
1,113
1,11311,653431682653902115332532532514,43834716587912915916620919441
       Property Plant Equipment 
39
192
209
166
159
129
79
58
16
7
4
3
3
1
0
0
325
3
123
109
235
138
43
85
824
82485431382351091233325001334716587912915916620919239
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
50
151
0
0
11,568
11,568
288
28811,56811,56800151505000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
325
325
325
0
0
0
0
0
0
0
0
0000000032532532500000000000000
       Intangible Assets 
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
223
37
130
30
30
30
11,568
0
011,5683030301303722300000000000000022
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
4,435
0
0
0
0
173
105
62
0
0
0
0
0
000006210517300004,435000000000000
> Total Liabilities 
112
539
640
1,013
1,203
1,114
663
391
1,106
442
175
96
1,022
913
427
229
458
610
729
829
726
745
815
2,687
3,398
3,3982,6878157457268297296104582294279131,022961754421,1063916631,1141,2031,013640539112
   > Total Current Liabilities 
112
539
640
1,013
1,192
1,107
659
388
1,106
442
175
96
1,022
913
427
229
458
610
729
829
726
745
815
2,687
2,907
2,9072,6878157457268297296104582294279131,022961754421,1063886591,1071,1921,013640539112
       Short-term Debt 
0
0
0
0
0
0
0
0
500
50
50
0
0
0
0
0
0
0
0
47
47
47
397
559
183
18355939747474700000000505050000000000
       Accounts payable 
112
466
508
887
769
874
551
261
394
274
55
14
638
380
238
131
215
335
417
433
220
176
204
1,205
1,193
1,1931,2052041762204334173352151312383806381455274394261551874769887508466112
       Other Current Liabilities 
0
73
132
126
423
233
108
127
212
118
70
82
384
533
189
99
243
274
312
396
458
569
214
1,482
1,495
1,4951,482214569458396312274243991895333848270118212127108233423126132730
   > Long-term Liabilities 
0
0
0
0
11
8
3
3
0
0
0
0
0
0
0
0
0
0
0
433
706
176
95
0
491
49109517670643300000000000338110000
       Other Liabilities 
0
0
0
0
11
8
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-5
0
0
00-500000000000000338110000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
173
105
62
0
0
0
0
0
000006210517300000000000000000
> Total Stockholder Equity
12,431
9,025
4,258
968
1,175
187
411
219
-623
43
123
124
5,888
-211
1,072
1,284
1,551
4,131
4,322
3,089
2,556
1,881
-365
15,137
3,606
3,60615,137-3651,8812,5563,0894,3224,1311,5511,2841,072-2115,88812412343-6232194111871,1759684,2589,02512,431
   Common Stock
13,858
13,561
13,597
15,411
19,956
22,900
24,990
26,444
26,934
27,761
27,761
27,761
28,034
28,127
57,427
57,427
57,478
60,816
62,178
62,178
62,178
62,178
129
17,548
18,998
18,99817,54812962,17862,17862,17862,17860,81657,47857,42757,42728,12728,03427,76127,76127,76126,93426,44424,99022,90019,95615,41113,59713,56113,858
   Retained Earnings -15,604-2,484-544-60,241-59,745-59,197-58,006-56,696-55,930-56,154-56,478-28,978-22,898-27,926-27,927-28,007-27,797-26,428-24,702-22,714-18,780-14,443-9,339-4,534-1,426
   Accumulated Other Comprehensive Income 
-1
-13
-83
-137
-147
-157
123
240
240
289
289
289
751
640
123
11
3
11
150
108
124
-56
50
73
212
2127350-5612410815011311123640751289289289240240123-157-147-137-83-13-1
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
1
10
83
137
147
157
0
-37
0
0
0
0
0
0
123
11
3
0
150
108
-2,432
-1,937
188
-15,064
0
0-15,064188-1,937-2,4321081500311123000000-37015714713783101



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.